Few Insured Individuals Receive Timely Direct-Acting Antiviral Treatment for Hepatitis C
Few insured individuals with hepatitis C virus (HCV) infection receive timely direct-acting antiviral (DAA) treatment.
Viral Hepatitis
Progress Observed in Proportion of Pregnant Individuals With Hepatitis C Screening
Percentage undergoing HCV screening test increased from 16.6 percent in quarter 1 of 2011 to 40.6 percent in quarter 2 of 2021
Two Highly Effective Direct-Acting Antiviral Regimens Identified for Hepatitis C Genotype 6
Researchers assessed the effectiveness of both sofosbuvir/velpatasvir and gelcaprevir/pibrentasvir among patients infected with hepatitis C genotype 6.
Preoperative Antiviral Treatment for Hepatitis C Virus Improves Total Joint Arthroplasty Outcomes
Researchers assessed the effect of preoperative antiviral treatment for hepatitis C virus on the risk for surgical-related complications in patients who underwent total joint arthroplasty.
Safety, Efficacy of DAAs for Hepatitis C Virus Genotype 6 Infection in People With HIV
A team of researchers analyzed the virologic response of hepatitis C virus to direct-acting antivirals in patients with HIV.
Analysis of Hepatitis C Virus Genotypes Among US Blood Donors From 2003 to 2018
Researchers assessed the characteristics and distribution of hepatitis C virus (HCV) genotypes among individuals with confirmed HCV infection who donated blood during a 16-year period.
Hepatology Clinic at a Methadone Center Increases Treatment Initiations for Hepatitis C Virus
Researchers assessed whether the rate of treatment initiations for hepatitis C virus infection among patients participating in a methadone treatment program increased after the implementation of a hepatology clinic.
Default Orders in the Electronic Health Record Increase Hepatitis C Screening Rates
Researchers conducted a study to determine whether the addition of a default screening order in the electronic health record increases the rate of hepatitis C virus screening among hospitalized patients.
Hepatitis C Transmission Risk From Syringes With Fixed vs Detachable Needles
Investigators conducted a study to determine the effect of syringes with fixed needles vs those with detachable needles on the risk for hepatitis C virus transmission among people who use injectable drugs.
ACIP: 2022 Adult Immunization Schedule Updates
The 2022 adult immunization schedule summarizes ACIP recommendations, including several changes.
- Loading...
Loading...
Loading... 
Loading...